Back
Live Nation Entertainment Vs. Aligos Therapeutics Industry Stock Comparison
Buy
58
LYV
Live Nation Entertainment
Last Price:
$128.64
Seasonality Move:
5.54%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$33.58
Seasonality Move:
-18.25%
Buy
58
Live Nation Entertainment (LYV)
is a Buy
Is Live Nation Entertainment a Buy, Sell or Hold?
-
The current Live Nation Entertainment [LYV] share price is $130.31. The Score for LYV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
LYV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.39. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LYV Stock Price Chart
What is Live Nation Entertainment's stock price today?
-
The Live Nation Entertainment share price today is $130.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYV is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.39The current trend is moderately bearish and ALGS is experiencing slight selling pressure.
LYV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 44.76 | Sell |
| Chaikin Money Flow: | 745741 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.55 - 136.13) | Sell |
| Bollinger Bands (100): | (102.91 - 132.89) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.47 | Buy |
| Relative Strength Index (14 RSI): | 56.78 | Buy |
| Chaikin Money Flow: | -32589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.39 - 41.59) | Buy |
| Bollinger Bands (100): | (6.9 - 29.68) | Buy |
LYV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.04 | Buy |
| 20-day SMA: | 132.7 | Sell |
| 50-day SMA: | 130.94 | Sell |
| 200-day SMA: | 106.37 | Buy |
| 8-day EMA: | 130.39 | Sell |
| 20-day EMA: | 131.74 | Sell |
| 50-day EMA: | 128.75 | Buy |
| 200-day EMA: | 110.94 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.2 | Sell |
| 20-day SMA: | 38.15 | Buy |
| 50-day SMA: | 25.97 | Buy |
| 200-day SMA: | 17.23 | Buy |
| 8-day EMA: | 40.71 | Sell |
| 20-day EMA: | 37.37 | Buy |
| 50-day EMA: | 29.03 | Buy |
| 200-day EMA: | 19.88 | Buy |
Live Nation Entertainment Earnings Growth & LYV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and an increase next year of $0.49 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Live Nation Entertainment Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||